Understand Your Brain,
Find Your Neurotype
Science-backed ADHD, Autism and IQ screening tests in 6 languages. Free to take. Optional AI-powered personalized report ($7.99).
Claude
AI analysis
Choose Your Screening Test
All tests are based on validated clinical instruments. Take 8–25 minutes.
ADHD Screening Test (ASRS-v1.1)
Based on the Adult ADHD Self-Report Scale (ASRS-v1.1) developed by the World Health Organization. This 18-question screener evaluates symptoms of inattention, hyperactivity, and impulsivity in adults.
Claude AI Analysis
Autism-Spectrum Quotient (AQ-10)
The AQ-10 is a shortened version of the Autism-Spectrum Quotient (AQ) developed by Simon Baron-Cohen and colleagues at the University of Cambridge. It measures autistic traits in adults.
Claude AI Analysis
Cognitive Abilities Assessment
A non-verbal matrix-based cognitive assessment measuring logical reasoning, pattern recognition, and abstract thinking. Inspired by Raven's Progressive Matrices principles.
Claude AI Analysis
Sensory Profile (SPQ)
Adult Sensory Processing Questionnaire (Blanche, Parham & Chang). 49 questions across 11 sensory patterns. Each pattern has validated clinical thresholds (Typical / Possible Difficulties / Definite Difficulties).
Claude AI Analysis
OCD Screening (OCI-R)
The Obsessive Compulsive Inventory Revised (OCI-R) is a validated 18-item tool developed by Foa et al. (2002) to screen for Obsessive-Compulsive Disorder. It measures six symptom dimensions: washing, obsessing, hoarding, ordering, checking, and neutralizing.
Claude AI Analysis
Anxiety Screening (GAD-7)
The Generalized Anxiety Disorder 7-item scale (GAD-7) is the most widely used validated tool for detecting and measuring anxiety severity. Developed at Columbia University, it is trusted by clinicians worldwide.
Claude AI Analysis
Depression Screening (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is the gold-standard validated tool for screening, diagnosing, monitoring, and measuring the severity of depression.
Claude AI Analysis
Dyspraxia / DCD Screener
Developmental Coordination Disorder (DCD), also known as dyspraxia, affects motor coordination and planning. It is found in approximately 5-6% of school-age children and often persists into adulthood. This screener assesses coordination difficulties, motor planning, and their impact on daily life.
Claude AI Analysis
Dyscalculia Screener
Dyscalculia is a specific learning difficulty that affects the ability to understand, process, and work with numbers and mathematical concepts. It affects approximately 5-7% of the population and is often co-occurring with ADHD and dyslexia.
Claude AI Analysis
Highly Sensitive Person (HSP) Scale
The HSP Scale by Dr. Elaine Aron (1996) assesses Sensory Processing Sensitivity (SPS), a validated personality trait present in ~15-20% of the population. HSP is not a disorder but a neurological trait.
Claude AI Analysis
Visual IQ — Raven Matrices
20 pure visual matrix questions testing abstract and non-verbal reasoning.
Claude AI Analysis
Verbal IQ — Language & Reasoning
20 questions covering analogies, vocabulary, odd-one-out and verbal categories.
Claude AI Analysis
Numerical IQ — Math & Logic
20 questions on number sequences, arithmetic reasoning, proportions and patterns.
Claude AI Analysis
Spatial IQ — 3D & Mental Rotation
20 questions testing spatial visualization, mental rotation and geometric logic.
Claude AI Analysis
Autism Spectrum Quotient (AQ-50)
Full 50-question AQ. 5 domains: Social Skills (SS), Attention Switching (AS), Attention to Detail (AD), Communication (CO), Imagination (IM). Clinical threshold: 32/50.
Claude AI Analysis
Dyslexia Screener
Dyslexia is a specific learning difficulty affecting reading, writing, and spelling. It is one of the most common learning differences, affecting approximately 10% of the population, and is unrelated to intelligence. This screener assesses core dyslexia indicators in reading, phonology, and working memory.
Claude AI Analysis
Complete IQ Assessment
The most comprehensive cognitive test: verbal, numerical, visual and spatial reasoning combined. Age-normed IQ score with full cognitive profile.
Claude AI Analysis
Burnout Screening (OLBI)
Assess your level of professional exhaustion and disengagement using the Oldenburg Burnout Inventory — 16 validated items.
Claude AI Analysis
High Potential Screening (HPI/HQI)
Explore cognitive, emotional and sensory traits associated with high intellectual potential — 20 items.
Claude AI Analysis
Sleep Quality Test (PSQI/Epworth)
Assess your sleep quality, insomnia symptoms and daytime sleepiness using validated clinical scales — 14 questions.
Claude AI Analysis
Alexithymia Test (TAS-20)
Discover your ability to identify, describe and process emotions — 20 items from the Toronto Alexithymia Scale.
Claude AI Analysis
Procrastination Test (Lay GPS)
Measure your tendency to delay tasks using the General Procrastination Scale — 20 validated items.
Claude AI Analysis
ADHD Child Screening (Conners)
Parent-completed screening for ADHD symptoms in children aged 6–17, based on the Conners Rating Scale — 18 items.
Claude AI Analysis
Trauma & PTSD Screening (PCL-5)
Assess post-traumatic stress symptoms using the PTSD Checklist for DSM-5 — 20 clinically validated items.
Claude AI Analysis
Screen & Internet Addiction Test (IAT)
Evaluate your relationship with screens and digital devices using the Internet Addiction Test — 20 items.
Claude AI Analysis
Learning Style Profile (VARK)
Discover whether you learn best Visually, Aurally, through Reading/writing, or Kinesthetically — 16 situational questions.
Claude AI Analysis
Interoceptive Awareness (MAIA)
Discover your level of body awareness across 8 dimensions: noticing, distraction, worry, attention, emotional awareness, self-regulation, body listening, and trusting your body — 32 validated items.
Claude AI Analysis
Adverse Childhood Experiences (ACE)
The ACE questionnaire is a 10-question screening tool measuring exposure to traumatic events during childhood (before age 18), including abuse, neglect, and household dysfunction. Developed by Felitti and colleagues at Kaiser Permanente and the CDC, it is one of the most widely used instruments for assessing the long-term impact of childhood adversity on adult health and wellbeing. Answer each question thinking about your first 18 years of life.
Claude AI Analysis
Bipolar Screening (MDQ)
The Mood Disorder Questionnaire (MDQ) is a 13-item screening tool developed by Hirschfeld and colleagues to identify symptoms of bipolar spectrum disorders in adults. Each question asks about a period of time in your life when you were not your usual self. A score of 7 or more "Yes" answers indicates a positive screen warranting further professional evaluation. The MDQ is widely used in primary care and research settings.
Claude AI Analysis
Depression Screening (CES-D)
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report questionnaire developed by Lenore Radloff at the US National Institute of Mental Health (NIMH) to measure depressive symptoms in the general population. It asks how often you have felt or behaved a certain way during the past week. A score of 16 or higher suggests elevated depressive symptoms that warrant further evaluation.
Claude AI Analysis
Autistic Camouflaging (CAT-Q)
The Camouflaging Autistic Traits Questionnaire (CAT-Q) measures the degree to which a person masks or camouflages their autistic characteristics. Camouflaging involves compensation (developing strategies to overcome difficulties), assimilation (trying to fit in), and masking (hiding characteristics). It is especially common in autistic women and people with ADHD.
Claude AI Analysis
Dissociation (DES-II)
The Dissociative Experiences Scale II (DES-II) is a 28-item self-report questionnaire developed by Eve Carlson and Frank Putnam (1993) to measure dissociative experiences in daily life. Dissociation refers to moments of disconnection from one's thoughts, memory, surroundings, actions, or identity. Everyone experiences mild dissociation occasionally (e.g., zoning out while driving), but persistent or intense dissociation can be linked to trauma, anxiety, or dissociative disorders. This simplified 5-point version measures how often each experience happens to you.
Claude AI Analysis
Bipolar Spectrum Screening (MDQ)
The Mood Disorder Questionnaire (MDQ) is the most widely validated tool for screening bipolar spectrum disorders. Developed by Dr Robert Hirschfeld, it screens for periods of unusually elevated or irritable mood that go beyond typical mood variation.
Claude AI Analysis
Social Anxiety Screening (SPIN)
The Social Phobia Inventory (SPIN) is a validated 17-item self-report tool for measuring social anxiety. It assesses fear, avoidance, and physiological arousal associated with social situations.
Claude AI Analysis
Rejection Sensitivity (RSD) Screener
Rejection Sensitive Dysphoria (RSD) is an intense emotional response to perceived or actual rejection, criticism, or failure — particularly common in individuals with ADHD and autism. This custom screener helps identify the presence and impact of rejection sensitivity.
Claude AI Analysis
Master Neurotype Test
A comprehensive multi-dimensional test that explores five core aspects of neurodivergence in a single assessment: attention (ADHD), social and sensory processing (autism spectrum), high sensitivity (HSP), rejection sensitivity (RSD), and emotional awareness (alexithymia). Get a complete picture of your unique neurotype in 8 minutes.
Claude AI Analysis
Rejection Sensitivity Test (RSD-12)
A 12-question screening for Rejection Sensitive Dysphoria (RSD), a pattern of intense emotional pain triggered by perceived or actual rejection, criticism or failure. Frequently associated with ADHD, autism and trauma. Measures three dimensions: emotional reactivity, behavioral avoidance, and cognitive distortion. Free, takes 4 minutes.
Claude AI Analysis
Psychosis Risk Screening (PQ-16)
The Prodromal Questionnaire (PQ-16) is a validated 16-item screening tool for unusual perceptual experiences and early psychotic symptoms. It takes ~5 minutes and was developed for use in general and clinical populations (Ising et al., 2012).
Claude AI Analysis
AI-Powered Analysis
Personalized Interpretation by Claude AI
After your test, Claude AI generates a compassionate, personalized narrative in your language — warm, non-clinical, and actionable.
- ✓ Warm, compassionate language
- ✓ Practical tailored suggestions
- ✓ Professional consultation guidance
- ✓ Available in 6 languages
What people are saying
Real results, real insights — from people just like you.
"The Claude AI interpretation described my daily struggles better than I could myself. Worth every penny."
"J'ai 34 ans et je comprends enfin pourquoi les interactions sociales m'ont toujours semblé épuisantes. Le PDF est excellent."
"Fast, professional, and accurate. The AI report gave me vocabulary to describe my symptoms to my GP."
"Der KI-Bericht war so präzise, dass ich ihn meiner Psychiaterin gezeigt habe. Sie war beeindruckt."
"Il rapporto PDF è dettagliato e professionale. Ottimo strumento prima di una valutazione clinica."
"Very thorough test. The recommendations section was particularly helpful — empathetic and practical."
Schizophrenia: Art, Hallucinations and the Brain
Artist Sue Morgan draws her hallucinations to get them out of her head. Clinician Sukhi Shergill uses MRI to look inside the brains of people living with schizophrenia. A short Nature documentary.
Read article →Medical Disclaimer: These tests are screening tools only and do not constitute a medical diagnosis. Always consult a qualified healthcare professional for clinical evaluation.